149 related articles for article (PubMed ID: 7355227)
1. Distribution and tissue dose of intraperitoneally administered radioactive chromic phosphate (32P) in New Zealand white rabbits.
Leichner PK; Rosenshein NB; Leibel SA; Order SE
Radiology; 1980 Mar; 134(3):729-34. PubMed ID: 7355227
[TBL] [Abstract][Full Text] [Related]
2. Effects of injection volume on the tissue dose, dose rate, and therapeutic potential intraperitoneal 32p.
Leichner PK; Cash SA; Backx C; Durand RE
Radiology; 1981 Oct; 141(1):193-9. PubMed ID: 7291525
[TBL] [Abstract][Full Text] [Related]
3. Intraperitoneal radioactive chromic phosphate (P32) in the treatment of ovarian cancer.
Powell JL; Kirchner AB
J Med Assoc Ga; 1984 Jan; 73(1):21-5. PubMed ID: 6707541
[No Abstract] [Full Text] [Related]
4. Phosphorus-32-chromic phosphate for ovarian cancer: I. Fractionated low-dose intraperitoneal treatments in conjunction with platinum analog chemotherapy.
Pattillo RA; Collier BD; Abdel-Dayem H; Ozker K; Wilson C; Ruckert AC; Hamilton K
J Nucl Med; 1995 Jan; 36(1):29-36. PubMed ID: 7799078
[TBL] [Abstract][Full Text] [Related]
5. The measurement of radiation doses from P32 chromic phosphate therapy of the peritoneum using SPECT.
Ott RJ; Flower MA; Jones A; McCready VR
Eur J Nucl Med; 1985; 11(8):305-8. PubMed ID: 3878292
[TBL] [Abstract][Full Text] [Related]
6. Pleuroperitoneal migration of intraperitoneal phosphorus-32-chromic phosphate therapy for stage I ovarian carcinoma.
Wilkinson RH
J Nucl Med; 1996 Apr; 37(4):636-9. PubMed ID: 8691256
[TBL] [Abstract][Full Text] [Related]
7. Dose estimation to the infant from breast milk following intraperitoneal administration of chromic phosphate 32P for the treatment of early ovarian cancer.
Sharma SC; Osborne RP; Jose B; Carlson JA
Health Phys; 1984 Sep; 47(3):452-4. PubMed ID: 6500947
[No Abstract] [Full Text] [Related]
8. Observations on the intraperitoneal distribution of chromic phosphate (32P) suspension for intraperitoneal therapy.
Sullivan DC; Harris CC; Currie JL; Wilkinson RH; Creasman WT
Radiology; 1983 Feb; 146(2):539-41. PubMed ID: 6849103
[TBL] [Abstract][Full Text] [Related]
9. CA-125 levels after surgical exploration and radioactive chromic phosphate in ovarian cancer patients.
Makhija S; Spanos WJ; Day TG; Doering D
Gynecol Oncol; 1996 Oct; 63(1):85-8. PubMed ID: 8898174
[TBL] [Abstract][Full Text] [Related]
10. Five and ten year estimated survival and disease-free rates after intraperitoneal chromic phosphate; stage I ovarian adenocarcinoma.
Piver MS; Lele SB; Bakshi S; Parthasarathy KL; Emrich LJ
Am J Clin Oncol; 1988 Oct; 11(5):515-9. PubMed ID: 3177251
[TBL] [Abstract][Full Text] [Related]
11. Intraperitoneal radioactive chromic phosphate P 32 in the treatment of ovarian cancer.
Powell JL; Burrell MO; Kirchner AB
South Med J; 1987 Dec; 80(12):1513-7. PubMed ID: 3423895
[TBL] [Abstract][Full Text] [Related]
12. Intraperitoneal chromic phosphate therapy after second-look laparotomy for ovarian cancer.
Varia M; Rosenman J; Venkatraman S; Askin F; Fowler W; Walton L; Halle J; Currie J
Cancer; 1988 Mar; 61(5):919-27. PubMed ID: 3338057
[TBL] [Abstract][Full Text] [Related]
13. Intraperitoneal distribution of 32P-chromic phosphate suspension in the dog.
Tewfik HH; Gruber H; Tewfik FA; Lifshitz SG
Int J Radiat Oncol Biol Phys; 1979 Oct; 5(10):1907-13. PubMed ID: 528257
[No Abstract] [Full Text] [Related]
14. Whole-body distribution of radioactivity after intraperitoneal administration of 32P colloids.
Boye E; Lindegaard MW; Paus E; Skretting A; Davy M; Jakobsen E
Br J Radiol; 1984 May; 57(677):395-402. PubMed ID: 6722434
[TBL] [Abstract][Full Text] [Related]
15. Colloidal chromic phosphate 32P synovectomy in antigen-induced arthritis in the rabbit.
Howson MP; Shepard NL; Mitchell NS
Clin Orthop Relat Res; 1988 Apr; (229):283-93. PubMed ID: 3349688
[TBL] [Abstract][Full Text] [Related]
16. Adjuvant intraperitoneal chromic phosphate therapy for women with apparent early ovarian carcinoma who have not undergone comprehensive surgical staging.
Soper JT; Berchuck A; Clarke-Pearson DL
Cancer; 1991 Aug; 68(4):725-9. PubMed ID: 1855171
[TBL] [Abstract][Full Text] [Related]
17. Adjuvant internal hepatic radiotherapy using colloidal 32P chromic phosphate in colorectal cancer.
Kim JY; Bom HS; Kim YJ; Choi W
Radiat Med; 1990; 8(6):246-9. PubMed ID: 2093946
[TBL] [Abstract][Full Text] [Related]
18. Ovarian carcinoma: adjuvant treatment with P-32.
Reddy S; Sutton GP; Stehman FB; Hornback NB; Ehrlich CE
Radiology; 1987 Oct; 165(1):275-8. PubMed ID: 3628782
[TBL] [Abstract][Full Text] [Related]
19. External beam pelvic radiotherapy plus intraperitoneal radioactive chronic phosphate in early stage ovarian cancer: a toxic combination. A National Cancer Institute of Canada Clinical Trials Group Report.
Klaassen D; Starreveld A; Shelly W; Miller A; Boyes D; Gerulath A; Levitt M
Int J Radiat Oncol Biol Phys; 1985 Oct; 11(10):1801-4. PubMed ID: 4044343
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic intraperitoneal 32P: a clinical assessment of the dynamics of distribution.
Kaplan WD; Zimmerman RE; Bloomer WD; Knapp RC; Adelstein SJ
Radiology; 1981 Mar; 138(3):683-8. PubMed ID: 7465847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
